查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1728092

家禽疫苗市場－全球產業規模、佔有率、趨勢、機會及預測（按應用、產品、疾病類型、地區和競爭細分，2020-2030 年）

Poultry Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application, By Product, By Disease Type, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年全球家禽疫苗市場價值為 18.9 億美元，預計到 2030 年將達到 27.8 億美元，預測期內複合年成長率為 6.64%。由於家禽養殖仍然是全球糧食供應的基石，家禽疫苗市場在維持家禽健康和確保糧食安全方面發揮著至關重要的作用。傳染性法氏囊病 (IBD) 等禽類疾病的盛行率不斷上升，加上家禽產品的日益普及，推動了對有效免疫策略的需求。最近的人畜共患病疫情和家禽病毒感染發病率的上升，特別是在非洲和亞洲等地區，進一步強調了廣泛疫苗接種計劃的必要性。疫苗開發技術的進步，包括重組疫苗和基於 DNA 的疫苗，正在促進市場的演變。此外，政府和獸醫組織越來越重視疾病管制，以防止家禽業的經濟損失，這強調了疫苗在維持家禽養殖生產力和健康標準的重要性。

市場概覽
預測期 2026-2030
2024年市場規模 18.9億美元
2030年市場規模 27.8億美元
2025-2030 年複合年成長率 6.64%
成長最快的領域 減毒活疫苗
最大的市場 北美洲

關鍵市場促進因素

全球家禽消費量上升

主要市場挑戰

疾病的複雜性和多變性

主要市場趨勢

精準疫苗接種

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：全球家禽疫苗市場展望

  • 市場規模和預測
    • 按價值
  • 市場佔有率和預測
    • 依用途（肉雞、蛋雞、種雞）
    • 依產品（減毒活疫苗、不活化疫苗、次單位疫苗、DNA疫苗、重組疫苗）
    • 依疾病類型（傳染性支氣管炎、傳染性法氏囊病、傳染性喉氣管炎、產蛋減少症候群、腺病毒、鴨病毒性腸炎、包涵體肝炎、沙門氏菌病、其他）
    • 按地區
    • 按公司分類（2024）
  • 產品市場圖
    • 按應用
    • 按產品
    • 依疾病類型
    • 按地區

第6章：北美家禽疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲家禽疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 歐洲：國家分析
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙

第8章：亞太家禽疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 亞太地區：國家分析
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國

第9章：南美洲家禽疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章：中東和非洲家禽疫苗市場展望

  • 市場規模和預測
  • 市場佔有率和預測
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 驅動程式
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 顧客的力量
  • 替代產品的威脅

第 14 章：競爭格局

  • Boehringer Ingelheim GmbH
  • Zoetis Inc
  • Elanco LLC
  • Intervet Inc
  • Hester Biosciences Ltd
  • Vaxxinova GmbH
  • Venky's India Ltd
  • Laboratorios Calier SA
  • KM Biologics Co Ltd
  • Phibro Animal Health Corporation

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 16323

The Global Poultry Vaccines Market was valued at USD 1.89 billion in 2024 and is projected to reach USD 2.78 billion by 2030, growing at a CAGR of 6.64% during the forecast period. As poultry farming remains a cornerstone of the global food supply, the market for poultry vaccines plays a vital role in maintaining flock health and ensuring food security. The increasing prevalence of avian diseases, such as Infectious Bursal Disease (IBD), coupled with the growing popularity of poultry products, is driving the demand for effective immunization strategies. Recent zoonotic outbreaks and the rising incidence of viral infections in poultry, particularly in regions like Africa and Asia, are further emphasizing the need for widespread vaccination programs. Technological advancements in vaccine development, including recombinant and DNA-based vaccines, are contributing to the market's evolution. Moreover, governments and veterinary organizations are increasingly focused on disease control to prevent economic losses in the poultry industry, reinforcing the importance of vaccines in sustaining productivity and health standards in poultry farming.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.89 Billion
Market Size 2030USD 2.78 Billion
CAGR 2025-20306.64%
Fastest Growing SegmentAttenuated Live Vaccine
Largest MarketNorth America

Key Market Drivers

Rising Global Poultry Consumption

The steady increase in global poultry consumption is significantly contributing to the expansion of the poultry vaccines market. Poultry, particularly chicken, has become a preferred protein source due to its affordability, nutritional value, and adaptability in diverse cuisines. As populations grow and urbanization accelerates, the demand for poultry meat and eggs continues to rise. This surge in consumption amplifies the need for disease prevention to protect flock health and ensure stable supply chains. Poultry farming is highly susceptible to disease outbreaks, which can result in massive financial losses and disruptions in production. Diseases like Newcastle disease, avian influenza, and coccidiosis are particularly prevalent and costly. For instance, a study reported in IJCMAS in October 2021 detailed financial losses ranging from INR 17,864 (USD 214) to INR 2,66,080 (USD 3,188.89) per farm due to Newcastle disease, further highlighting the critical need for robust vaccination programs. As a result, maintaining flock health through vaccination is becoming a key strategy for producers to safeguard economic returns and meet growing consumer demand.

Key Market Challenges

Disease Complexity and Variability

The poultry vaccines market faces notable challenges stemming from the complexity and variability of infectious diseases affecting poultry. Poultry are vulnerable to a broad spectrum of pathogens, including viruses, bacteria, and parasites, each with multiple strains and high mutation rates. This diversity complicates the development of vaccines that can offer comprehensive and long-lasting protection. Continual pathogen evolution necessitates constant updates in vaccine formulations, increasing research and development costs. Moreover, the unpredictable emergence of novel variants can outpace the availability of suitable vaccines, undermining disease control efforts and adding uncertainty to vaccine efficacy.

Key Market Trends

Precision Vaccination

Precision vaccination is emerging as a key trend in the poultry vaccines market, with the focus shifting toward more targeted and efficient immunization strategies. This approach tailors vaccination programs based on specific factors such as the age, health status, and risk profile of poultry flocks. Through the use of data analytics and advanced monitoring systems, precision vaccination enables better disease forecasting and more accurate administration schedules. The result is enhanced vaccine effectiveness, reduced wastage, and cost optimization. This trend aligns with the broader movement toward data-driven, sustainable practices in animal agriculture and reflects the industry's commitment to maximizing productivity while minimizing intervention-related costs.

Key Market Players

  • Boehringer Ingelheim GmbH
  • Zoetis Inc
  • Elanco LLC
  • Intervet Inc
  • Hester Biosciences Ltd
  • Vaxxinova GmbH
  • Venky's India Ltd
  • Laboratorios Calier SA
  • KM Biologics Co Ltd
  • Phibro Animal Health Corporation

Report Scope:

In this report, the Global Poultry Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Poultry Vaccines Market, By Application:

  • Broiler
  • Layer
  • Breeder

Poultry Vaccines Market, By Product:

  • Attenuated Live Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Poultry Vaccines Market, By Disease Type:

  • Infectious Bronchitis
  • Infectious Bursal Diseases
  • Infectious Laryngotracheitis
  • Egg Drop Syndrome
  • Adenovirus
  • Duck Viral Enteritis
  • Inclusion Body Hepatitis
  • Salmonella
  • Others

Poultry Vaccines Market, By Region:

  • North America
    • United States
    • Mexico
    • Canada
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia-Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Poultry Vaccines Market.

Available Customizations:

Global Poultry Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Poultry Vaccines Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Application (Broiler, Layer, Breeder)
    • 5.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 5.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Product Market Map
    • 5.3.1. By Application
    • 5.3.2. By Product
    • 5.3.3. By Disease Type
    • 5.3.4. By Region

6. North America Poultry Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Application (Broiler, Layer, Breeder)
    • 6.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 6.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Poultry Vaccines Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Application
        • 6.3.1.2.2. By Product
        • 6.3.1.2.3. By Disease Type
    • 6.3.2. Canada Poultry Vaccines Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Application
        • 6.3.2.2.2. By Product
        • 6.3.2.2.3. By Disease Type
    • 6.3.3. Mexico Poultry Vaccines Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Application
        • 6.3.3.2.2. By Product
        • 6.3.3.2.3. By Disease Type

7. Europe Poultry Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Application (Broiler, Layer, Breeder)
    • 7.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 7.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Poultry Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Application
        • 7.3.1.2.2. By Product
        • 7.3.1.2.3. By Disease Type
    • 7.3.2. United Kingdom Poultry Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Application
        • 7.3.2.2.2. By Product
        • 7.3.2.2.3. By Disease Type
    • 7.3.3. France Poultry Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Application
        • 7.3.3.2.2. By Product
        • 7.3.3.2.3. By Disease Type
    • 7.3.4. Italy Poultry Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Application
        • 7.3.4.2.2. By Product
        • 7.3.4.2.3. By Disease Type
    • 7.3.5. Spain Poultry Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Application
        • 7.3.5.2.2. By Product
        • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Poultry Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Application (Broiler, Layer, Breeder)
    • 8.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 8.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Poultry Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Application
        • 8.3.1.2.2. By Product
        • 8.3.1.2.3. By Disease Type
    • 8.3.2. Japan Poultry Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Application
        • 8.3.2.2.2. By Product
        • 8.3.2.2.3. By Disease Type
    • 8.3.3. India Poultry Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Application
        • 8.3.3.2.2. By Product
        • 8.3.3.2.3. By Disease Type
    • 8.3.4. Australia Poultry Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Application
        • 8.3.4.2.2. By Product
        • 8.3.4.2.3. By Disease Type
    • 8.3.5. South Korea Poultry Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Application
        • 8.3.5.2.2. By Product
        • 8.3.5.2.3. By Disease Type

9. South America Poultry Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Application (Broiler, Layer, Breeder)
    • 9.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 9.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Poultry Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Application
        • 9.3.1.2.2. By Product
        • 9.3.1.2.3. By Disease Type
    • 9.3.2. Argentina Poultry Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Application
        • 9.3.2.2.2. By Product
        • 9.3.2.2.3. By Disease Type
    • 9.3.3. Colombia Poultry Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Application
        • 9.3.3.2.2. By Product
        • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Poultry Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Application (Broiler, Layer, Breeder)
    • 10.2.2. By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines)
    • 10.2.3. By Disease Type (Infectious Bronchitis, Infectious Bursal Diseases, Infectious Laryngotracheitis, Egg Drop Syndrome, Adenovirus, Duck Viral Enteritis, Inclusion Body Hepatitis, Salmonella, Others)
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Poultry Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Application
        • 10.3.1.2.2. By Product
        • 10.3.1.2.3. By Disease Type
    • 10.3.2. Saudi Arabia Poultry Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Application
        • 10.3.2.2.2. By Product
        • 10.3.2.2.3. By Disease Type
    • 10.3.3. UAE Poultry Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Application
        • 10.3.3.2.2. By Product
        • 10.3.3.2.3. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Porter's Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Boehringer Ingelheim GmbH
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Zoetis Inc
  • 14.3. Elanco LLC
  • 14.4. Intervet Inc
  • 14.5. Hester Biosciences Ltd
  • 14.6. Vaxxinova GmbH
  • 14.7. Venky's India Ltd
  • 14.8. Laboratorios Calier SA
  • 14.9. KM Biologics Co Ltd
  • 14.10. Phibro Animal Health Corporation

15. Strategic Recommendations

16. About Us & Disclaimer